APA (7th ed.) Citation

Mazzaschi, G., Lazzarin, A., Santoni, M., Trentini, F., Giorgi, U. D., Brighi, N., . . . Buti, S. (2023). Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score. IMR Press.

Chicago Style (17th ed.) Citation

Mazzaschi, Giulia, et al. Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score. IMR Press, 2023.

MLA (9th ed.) Citation

Mazzaschi, Giulia, et al. Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score. IMR Press, 2023.